Clinical Trial

Genome Driven Primary Care Clinics - an RCT

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 4, 2021 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
A cluster randomized controlled study of 40 primary care clinics in Northern Israel (20 intervention clinics, 20 usual care clinics) to evaluate the value of introducing a precision medicine/genomic approach/paradigm on the clinical and economical outcomes of the clinics. Intervention includes 3 elements: 1. DNA extraction and evaluation (up to the level of WGS); 2. Feces sample for microbiome study, 3. Wearable devices for continuous monitoring of body functions. Expected number of participants is 100,000 in each arm. Results will be calculated for a clinic as a unit and not for individuals (each clinic to be compared to "twin" selected clinic).
Trial Details
NCT Number NCT04781205
Lead Sponsor Carmel Medical Center
Conditions Health Services Administration, Genetic Predisposition, Microbial Colonization
Enrollment 200,000 participants
Start Date 2019-05-01
Primary Completion 2025-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2021-03-04